Property developer Greenland Holdings has returned to reinvest in mobile broadband infrastructure provider Baicells as part of a nine-digit renminbi round.
Month: June 2020
Healthy ageing – a new stage for opportunity and strength
The demographic phenomenon of ageing populations will present challenges to both developed and developing nations. Along with the challenges come opportunities, however, and corporate venture capitalists may be a particularly well-positioned group to help with them, as it is the connecting tissue between the world of incumbent corporate industry leaders and the space of disruptive innovation.
Healthy ageing looks beyond dying with grace
Healthy Ageing Q2 2020 editorial by James Mawson, editor in chief, Global Corporate Venturing
Steady gets Recruit in $15m series B
The gig worker support service secured $15m in a round led by Recruit Strategic Partners that also featured CMFG Ventures and existing investor Propel Venture Partners.
Drishti produces $25m series B
Toyota AI Ventures, Micron Ventures, Hella Ventures and Presidio Ventures have all invested in the video analytics system developer.
Clockwise locks in $18m
Slack-backed smart calendar developer Clockwise has now raised $31m altogether, Bain Capital Ventures having led its series B round.
Streamlit strikes up $21m series A
Existing investors Gradient Ventures and Bloomberg Beta returned for a round that took the machine learning software developer’s total funding to $27m.
Governments need to cure old habits of control
The traditional way to think of supporting entrepreneurs has been to look at their five primary needs: access to capital, finding customers, product and service development, hiring people and, eventually, an exit.
Forma Therepeutics prepares for public markets
Novartis and Eli Lilly are set to score exits from the cancer and blood disease drug developer in an initial public offering set to raise up to $212m.
4DMT goes forward with $75m
Pfizer Ventures and Chiesi Ventures returned to back inherited disease therapy developer 4D Molecular Therapeutics, which filed to go public in September.
Volkswagen to drive $200m to QuantumScape
The carmaker has followed up a $100m investment two years ago with a pledge to provide up to $200m for the solid-state battery developer.
C4 Therapeutics seals $170m round
The Roche, Novartis and Kraft Group-backed, protein degradation-focused drug developer received $150m in series B funding and $20m in venture debt.
Corporates chip in as BYD Semiconductor gets $113m
SK China, Xiaomi and Lenovo were among the investors as BYD’s electric vehicle chip spinoff added $113m to the $265m it announced last month.
GreenLight filters through $102m
Continental Grain invested in a series D round that boosted the RNA technology provider’s overall funding to $214m as it allocates more resources to vaccine work.